Medical expulsive therapy in children with urolithiasis in the foreign practice: a literature review

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Urolithiasis in children is a common disease nowadays. In many countries, medical expulsive therapy is actively used in such cases. The purpose of this research is to highlight principles and effectiveness of medical expulsive therapy, as well as advantages and disadvantages of α1-blockers over other pharmpreparations in children with urolithiasis. In the present review, the researchers have analyzed literature publications from 2004 to 2023. This systemic review was made using databases of Cochrane, PubMed, Web of Science, Scopus for the period from 2004 to 2023. The following Key words were used for search: urolithiasis, medical expulsive therapy. 32 full-text articles were included in the study.

While assessing results of medical expulsive therapy application in children with urolithiasis, it was noted that α1-blockers can significantly increase stone expulsion rate and reduce expulsion time. Side-effects of the discussed technique are insignificant. They include: headache, dizziness, orthostatic hypotension or nasal congestion. Medical expulsive therapy is reasonable for application due to its high efficiency and due to α1-blockers safety in children with urolithiasis. At present, adrenergic receptor blockers for medical expulsive therapy in children with urolithiasis are not allowed in Russia.

全文:

受限制的访问

作者简介

Ibragim Kyarimov

National Medical Research Center for Children's Health

编辑信件的主要联系方式.
Email: ibragim.kyarimov@bk.ru
ORCID iD: 0000-0003-4529-9926
SPIN 代码: 8417-8649

MD

俄罗斯联邦, 2/62 Lomonosovsky avenue, 119296 Moscow

Sergey Zorkin

National Medical Research Center for Children's Health

Email: zorkin@nczd.ru
ORCID iD: 0000-0002-2731-5008
SPIN 代码: 4762-8837

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, 2/62 Lomonosovsky avenue, 119296 Moscow

Antonina Lobanova

National Medical Research Center for Children's Health

Email: lobanova.ad@nczd.ru
ORCID iD: 0000-0001-7971-5073

MD

俄罗斯联邦, 2/62 Lomonosovsky avenue, 119296 Moscow

Svetlana Kosobutskaya

National Medical Research Center for Children's Health

Email: kosobutskaia.sa@nczd.ru
ORCID iD: 0000-0002-5484-9574
SPIN 代码: 2589-3752

MD, Cand. Sci. (Medicine)

俄罗斯联邦, 2/62 Lomonosovsky avenue, 119296 Moscow

参考

  1. Bosshard P, Stritt K, Roth B. Prise en charge de la lithiase urétérale. Rev Med Suisse. 2020;16(717):2321–2324. (In French) EDN: DMZUGO
  2. Grivas N, Thomas K, Drake T, et al. Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines panel. J Pediatr Urol. 2020;16(5):612–624. doi: 10.1016/j.jpurol.2020.07.003
  3. Tasian GE, Kabarriti AE, Kalmus A, Furth SL. Kidney stone recurrence among children and adolescents. J Urol. 2017;197(1): 246–252. doi: 10.1016/j.juro.2016.07.090
  4. Smeulders N, Cho A, Alshaiban A, et al. Shockwaves and the Rolling Stones: An overview of pediatric stone disease. Kidney Int Rep. 2023;8(2):215–228. EDN: XWUIOA doi: 10.1016/j.ekir.2022.11.017
  5. Juliebo-Jones P, Keller EX, Tzelves L, et al. Paediatric kidney stone surgery: State-of-the-art review. Ther Adv Urol. 2023;(15):17562872231159541. EDN: BVPZQB doi: 10.1177/17562872231159541
  6. Tekgul S, Stein R, Bogaert G, et al. European Association of Urology and European Society for Pediatric Urology guidelines on pediatric urinary stone disease. Eur Urol Focus. 2022;8(3):833–839. EDN: DFPDWB doi: 10.1016/j.euf.2021.05.006
  7. Nakada SY. Tamsulosin: Ureteric motility. BJU Int. 2008;101(9):1061–1062. doi: 10.1111/j.1464-410X.2008.07552.x
  8. Roehrborn CG, Schwinn DA. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol. 2004;171(3):1029–1035. doi: 10.1097/01.ju.0000097026.43866.cc
  9. Atan A, Polat F, Turkyilmaz Z, Sonmez K. Areas of alpha-1 receptor blocker usage in pediatric urology. GMJ. 2020;31(3): 457–459. doi: 10.12996/gmj.2020.112
  10. Ellison JS, Merguerian PA, Fu BC, et al. Use of medical expulsive therapy in children: An assessment of nationwide practice patterns and outcomes. J Pediatr Urol. 2017;13(5):509.e1–509.e7. doi: 10.1016/j.jpurol.2017.03.022
  11. Kaler KS, Safiullah S, Lama DJ, et al. Medical impulsive therapy (MIT): The impact of 1 week of preoperative tamsulosin on deployment of 16-french ureteral access sheaths without preoperative ureteral stent placement. World J Urol. 2018;36(12):2065–2071. doi: 10.1007/s00345-018-2336-1
  12. McGee LM, Sack BS, Wan J, et al. The effect of preoperative tamsulosin on ureteroscopic access in school-aged children. J Pediatr Urol. 2021;17(6):795.e1–795.e6. doi: 10.1016/j.jpurol.2021.08.021
  13. Barreto L, Jung JH, Abdelrahim A, et al. Medical and surgical interventions for the treatment of urinary stones in children. Cochrane Database Syst Rev. 2018;(6):CD010784. doi: 10.1002/14651858.CD010784.pub2
  14. Tian D, Li N, Huang W, et al. The efficacy and safety of adrenergic alpha-antagonists in treatment of distal ureteral stones in pediatric patients: A systematic review and meta-analysis. J Pediatr Surg. 2017;52(2):360–365. doi: 10.1016/j.jpedsurg.2016.10.003
  15. Velázquez N, Zapata D, Wang HH, et al. Medical expulsive therapy for pediatric urolithiasis: Systematic review and meta-analysis. J Pediatr Urol. 2015;11(6):321–327. doi: 10.1016/j.jpurol.2015.04.036
  16. Aldaqadossi HA, Shaker H, Saifelnasr M, Gaber M. Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab J Urol. 2015;13(2):107–111. doi: 10.1016/j.aju.2015.02.007
  17. Taguchi K, Cho SY, Ng AC, et al. The urological association of Asia clinical guideline for urinary stone disease. Int J Urol. 2019;26(7): 688–709. EDN: AWRQOM doi: 10.1111/iju.13957
  18. Ma L, Zou S, Yang L, Wang F. Efficacy and safety of doxazosin in medical expulsive therapy for distal ureteral stones: A systematic review and meta-analysis. Urol J. 2020;17(5):449–455. doi: 10.22037/uj.v16i7.5958
  19. Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha blockers in medical expulsive therapy for ureteral stones: A mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018;11(3):291–307. doi: 10.1080/17512433.2018.1424537
  20. Tuerxun A, Batuer A, Erturhan S, et al. Impaction and prediction: Does ureteral wall thickness affect the success of medical expulsive therapy in pediatric ureteral stones? Urol Int. 2017;98(4):436–441. doi: 10.1159/000453668
  21. Elgalaly H, Eliwa A, Seleem M, et al. Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo-controlled study. Arab J Urol. 2017;15(3):194–198. doi: 10.1016/j.aju.2017.05.005
  22. Soliman MG, El-Gamal O, El-Gamal S, et al. Silodosin versus tamsulosin as medical expulsive therapy for children with lower-third ureteric stones: Prospective randomized placebo-controlled study. Urol Int. 2021;105(7-8):568–573. doi: 10.1159/000513074
  23. Huang W, Xue P, Zong H, Zhang Y. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81(1):13–22. doi: 10.1111/bcp.12737
  24. Brohi IB, Bhatti MS, Siyal RA, et al. Efficacy of alpha-adrenergic receptor antagonists in the treatment of distal ureteric stones: A paediatric study. J Ayub Med Coll Abbottabad. 2022;34(4): 807–811.е 815. EDN: CSUNRT doi: 10.55519/JAMC-04-10379
  25. Nelson R, Stamm J, Timmons Z, Grimsby GM. Management of pediatric ureterolithiasis in the emergency room: A single institution review and new management pathway. J Pediatr Urol. 2023;19(2):177.e1–177.e6. EDN: QIBBMX doi: 10.1016/j.jpurol.2022.11.015
  26. Sun K, Zhang P, Sun Y, et al. Meta-analysis of the efficacy and adverse drug reactions of adrenergic alpha-antagonists in treating children with ureteral calculi. Front Pediatr. 2023;(11):1098002. EDN: VRGBUX doi: 10.3389/fped.2023.1098002
  27. Ziaeefar P, Basiri A, Zangiabadian M, et al. Medical expulsive therapy for pediatric ureteral stones: A meta-analysis of randomized clinical trials. J Clin Med. 2023;12(4):1410. EDN: TANEKL doi: 10.3390/jcm12041410
  28. Sun F, Bao X, Cheng D, et al. Meta-analysis of the safety and efficacy of α-adrenergic blockers for pediatric urolithiasis in the distal ureter. Front Pediatr. 2022;(10):809914. EDN: NGGWOB doi: 10.3389/fped.2022.809914
  29. Telli O, Gokce MI, Ozturk E, et al. What is the best option for 10–20 mm renal pelvic stones undergoing ESWL in thepediatricpopulation: Stenting, alphablockersor conservative follow-up? J Pediatr Surg. 2015;50(9):1532–1534. doi: 10.1016/j.jpedsurg.2014.11.045
  30. Shahat A, Elderwy A, Safwat AS, et al. Is tamsulosin effective after shock wave lithotripsy for pediatric renal stones? A randomized, controlled study. J Urol. 2016;195(4, Pt 2):1284–1288. doi: 10.1016/j.juro.2015.11.021
  31. Oestreich MC, Vernooij RW, Sathianathen NJ, et al. Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. Cochrane Database Syst Rev. 2020;11(11):CD013393. doi: 10.1002/14651858.CD013393.pub2
  32. Belousov II, Yassine AM, Kogan MI. The dynamics of urinary stone disease of the proximal ureter and the effectiveness of silodosin for treatment of urolithiasis after extracorporeal shock wave lithotripsy. Eksperimental’naya i klinicheskaya urologiya. 2017;(3):58–63. EDN: ZSRQOJ

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Kyarimov I.A., Zorkin S.N., Lobanova A.D., Kosobutskaya S.A., 2024

##common.cookie##